We are live on
!
Find out more
EAM
EFG Asset Management Portfolio holdings
AUM
$773M
1-Year Est. Return
40.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.52%
1 Year Est. Return
+40.1%
3 Year Est. Return
+211.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$421M
AUM Growth
-$44.9M
(-9.6%)
Cap. Flow
-$19.8M
Cap. Flow
% of AUM
-4.71%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
207
New
16
Increased
62
Reduced
115
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$2.72M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$1.86M |
| 3 |
Roivant Sciences
ROIV
|
+$1.84M |
| 4 |
Certara
CERT
|
+$1.81M |
| 5 |
GE HealthCare
GEHC
|
+$1.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CoStar Group
CSGP
|
+$4.92M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
+$3.38M |
| 3 |
Doximity
DOCS
|
+$2.9M |
| 4 |
Wolfspeed
WOLF
|
+$2.44M |
| 5 |
Dick's Sporting Goods
DKS
|
+$1.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.85% |
| 2 | Technology | 22.51% |
| 3 | Industrials | 10.95% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Veeva Systems
VEEV
$30B
| $10.9M | 2.59% |
53,673
-1,864
| -3% | -$376K |
|
2
Idexx Laboratories
IDXX
$43B
| $9.33M | 2.22% |
21,333
-453
| -2% | -$226K |
|
3
Apple
AAPL
$4.79T
| $6.95M | 1.65% |
40,600
-3,002
| -7% | -$551K |
|
4
Ares Management
ARES
$27B
| $6.73M | 1.6% |
65,365
-5,303
| -8% | -$536K |
|
5
Trade Desk
TTD
$8.26B
| $6.12M | 1.45% |
78,277
-9,773
| -11% | -$790K |
|
|
6
BioMarin Pharmaceuticals
BMRN
$11.3B
| $5.96M | 1.41% |
67,322
+20,874
| +45% | +$1.86M |
|
7
Deckers Outdoor
DECK
$14.2B
| $5.92M | 1.41% |
69,024
-744
| -1% | -$66.6K |
|
8
Spotify
SPOT
$97.5B
| $5.73M | 1.36% |
37,073
-399
| -1% | -$60.8K |
|
9
Verisk Analytics
VRSK
$25.2B
| $5.65M | 1.34% |
23,935
-2,070
| -8% | -$488K |
|
10
Fair Isaac
FICO
$28.3B
| $5.61M | 1.33% |
6,462
-34
| -0.5% | -$29.2K |
|
11
Intuitive Surgical
ISRG
$121B
| $5.58M | 1.33% |
19,097
-1,082
| -5% | -$338K |
|
12
Natera
NTRA
$37.8B
| $5.5M | 1.31% |
124,259
-5,792
| -4% | -$295K |
|
13
Amazon
AMZN
$2.63T
| $5.28M | 1.25% |
41,540
+3,189
| +8% | +$427K |
|
14
Halozyme
HALO
$9.23B
| $5.26M | 1.25% |
137,739
-3,842
| -3% | -$157K |
|
15
Alphabet (Google) Class A
GOOGL
$4.17T
| $5.25M | 1.25% |
40,119
+1,995
| +5% | +$258K |
|
16
LPL Financial
LPLA
$26.2B
| $5.22M | 1.24% |
21,971
-1,295
| -6% | -$301K |
|
17
Veracyte
VCYT
$4.63B
| $5.13M | 1.22% |
229,837
-17,855
| -7% | -$459K |
|
18
MongoDB
MDB
$24.5B
| $5.05M | 1.2% |
14,597
-2,017
| -12% | -$766K |
|
19
argenx
ARGX
$53.3B
| $4.97M | 1.18% |
10,115
-1,389
| -12% | -$679K |
|
20
Alnylam Pharmaceuticals
ALNY
$35.6B
| $4.93M | 1.17% |
27,851
-300
| -1% | -$57.2K |
|
21
Legend Biotech
LEGN
$4.55B
| $4.84M | 1.15% |
72,072
-9,041
| -11% | -$628K |
|
22
Rockwell Automation
ROK
$51B
| $4.69M | 1.11% |
16,385
+2,735
| +20% | +$846K |
|
23
Molina Healthcare
MOH
$11.6B
| $4.6M | 1.09% |
14,011
-976
| -7% | -$307K |
|
24
NVIDIA
NVDA
$5.14T
| $4.45M | 1.06% |
102,260
-12,400
| -11% | -$556K |
|
25
Quanta Services
PWR
$96.5B
| $4.39M | 1.04% |
23,448
-253
| -1% | -$50.7K |
|
Similar funds
HWM
CP
BVDMP
MSAM
WA
PAS
NSEDCP
RAM
EFG Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, EFG Asset Management held 207 positions worth $421M, down 9.6% from $466M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
EFG Asset Management withdrew a net $19.8M in Q3 2023, closing 14 positions and reducing 115 holdings. Its most notable exit was CoStar Group, an estimated $4.92M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 38% a quarter earlier, followed by Technology and Industrials.
Against the trend, EFG Asset Management opened a new position in Zscaler worth $2.82M.
- EFG Asset Management's largest Q3 2023 buy was Zscaler: 18,131 shares worth $2.82M.
- EFG Asset Management added most to BioMarin Pharmaceuticals in Q3 2023, an estimated $1.86M increase.
- EFG Asset Management's biggest Q3 2023 reduction was Blueprint Medicines, cutting an estimated $3.38M.
- EFG Asset Management fully exited CoStar Group in Q3 2023, selling an estimated $4.92M.
- EFG Asset Management's ten largest holdings make up 16% of its $421M portfolio in Q3 2023.
- EFG Asset Management opened 16 new positions and closed 14 in Q3 2023.
- EFG Asset Management's portfolio value fell 9.6% quarter-over-quarter to $421M.
Based on EFG Asset Management's 13F filing for Q3 2023, filed 2 Nov 2023.